
NASDAQHealthcareDrug Manufacturers - Specialty & Generic
أحدث البيانات المتاحة
6.45 US$
+0.02 US$ · +0.31%
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
الإغلاق السابق
6.45 US$
+0.02 US$ · +0.31%
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
نطاق اليوم
السعر الحالي 6.45 US$
نطاق 52 أسبوعًا
السعر الحالي 6.45 US$
تستخدم الأوقات اليومية المنطقة الزمنية ET. قد تتأخر بيانات السوق.
نقاط GoAI
بيع
تقييم
47
قيمة عادلة
المشاعر
52
مختلط
المخاطر
68
مخاطر مرتفعة
الزخم
26
زخم متراجع
بحث كامل عن GoAI
تابع للاطلاع على أدلة ومحفزات ومخاطر أعمق.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It provides services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials, and cartridges in various modalities. The company also manufactures and sells pharmaceutical-grade hyaluronic acid in bulk form, as well as for use in formulated and filled syringes and vials for injectable products used in treating various medical conditions and procedures, including ophthalmic and orthopedic applications. In addition, it offers product development services, including analytical method development and validation, formulation development, sterile filtration, process scale-up, pilot studies, stability studies, process validation, and materials production for clinical studies. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.
نطاق اليوم
السعر الحالي 6.45 US$
نطاق 52 أسبوعًا
السعر الحالي 6.45 US$
الربحية كنسبة مئوية من الإيرادات المعلنة.
الإيرادات
الدخل التشغيلي
صافي الدخل
| البند (USD) | السنة المالية 2026 | السنة المالية 2025 | السنة المالية 2024 | السنة المالية 2023 | السنة المالية 2022 |
|---|---|---|---|---|---|
| الإيرادات | 129.46 مليون USD | 128.87 مليون USD | 128.26 مليون USD | 103.27 مليون USD | 111.27 مليون USD |
| تكلفة البضاعة المباعة | 88.85 مليون USD | 88.57 مليون USD | 86.41 مليون USD | 75.28 مليون USD | 72.2 مليون USD |
| الربح الإجمالي | 40.61 مليون USD | 40.3 مليون USD | 41.85 مليون USD | 27.99 مليون USD | 39.07 مليون USD |
| البحث والتطوير | 8.5 مليون USD | 8.26 مليون USD | 8.58 مليون USD | 8.74 مليون USD | 7.84 مليون USD |
| مصاريف البيع والمصاريف العمومية والإدارية | 33.35 مليون USD | 44.05 مليون USD | 40.46 مليون USD | 38.97 مليون USD | 34.66 مليون USD |
| نفقات التشغيل | 41.87 مليون USD | 57.54 مليون USD | 50.69 مليون USD | 49.78 مليون USD | 50.86 مليون USD |
| دخل الفوائد | — | — | — | 68 ألف USD | 81 ألف USD |
| مصاريف الفوائد | −2.21 مليون USD | 21.84 مليون USD | 18.09 مليون USD | 17.65 مليون USD | 15.55 مليون USD |
| الاستهلاك والإطفاء | 9.5 مليون USD | 8.03 مليون USD | 7.95 مليون USD | 13.18 مليون USD | 18.06 مليون USD |
| الدخل التشغيلي | −1.26 مليون USD | −17.25 مليون USD | −8.84 مليون USD | −21.8 مليون USD | −11.79 مليون USD |
| صافي الدخل | −30.79 مليون USD | −38.72 مليون USD | 12.01 مليون USD | −99.56 مليون USD | −116.72 مليون USD |
تم تحديث حقائق الشركة 11 أكتوبر 2026.
أحدث النتائج المعلنة
أحدث النتائج المعلنة
قد تتغير تقديرات المحللين الخارجيين، وهي ليست توصيات من GoAI.
متوسط الهدف
6.39 US$
انخفاض محتمل بنسبة 0.93%صناديق متداولة تفصح عن تعرضها لهذا السهم.
iShares Russell 2000 ETFIWM4.79 مليون0.01%78.74 مليار USD0.19%278.94 US$+0.49%
Vanguard Morningstar Total Stock Market ETFVTI3.67 مليون0.00%2.3 ترليون USD0.03%381.94 US$+0.63%
Vanguard Extended Market ETFVXF1.94 مليون0.00%95.4 مليار USD0.05%235 US$+0.80%
Vanguard Russell 2000 ETFVTWO729.42 ألف0.00%18 مليار USD0.06%112.66 US$+0.50%
iShares Micro-Cap ETFIWC578.13 ألف0.04%1.32 مليار USD0.60%183 US$+0.11%
Vanguard Russell 2000 Value ETFVTWV110.63 ألف0.01%1.4 مليار USD0.06%185.81 US$-0.13%
Global X - Russell 2000 ETFRSSL87.81 ألف0.01%1.42 مليار USD0.08%109.09 US$+0.21%
ProShares Russell 2000 High Income ETFITWO10.62 ألف0.01%184.98 مليون USD0.55%43.06 US$+0.96%
iShares Russell 2000 ETFIWM
Vanguard Morningstar Total Stock Market ETFVTI
Vanguard Extended Market ETFVXF
Vanguard Russell 2000 ETFVTWO
iShares Micro-Cap ETFIWC
Vanguard Russell 2000 Value ETFVTWV
Global X - Russell 2000 ETFRSSL
ProShares Russell 2000 High Income ETFITWOالمحتوى المُنشأ بالذكاء الاصطناعي وبيانات السوق المتأخرة لأغراض معلوماتية وتعليمية فقط، ولا تُعد نصيحة استثمارية.